These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2220325)
21. A pathological study of the association between Lewy body disease and Alzheimer's disease. Gibb WR; Mann DM; Mountjoy CQ; Lees AJ Adv Neurol; 1990; 53():55-9. PubMed ID: 2173375 [No Abstract] [Full Text] [Related]
23. A review of neuropathological and neurochemical correlates of Alzheimer's disease. Perry EK; Perry RH Dan Med Bull; 1985 Feb; 32 Suppl 1():27-34. PubMed ID: 2859148 [No Abstract] [Full Text] [Related]
24. Amyloid plaques, neurofibrillary tangles and their relevance for the study of Alzheimer's disease. Goedert M; Crowther RA Neurobiol Aging; 1989; 10(5):405-6; discussion 412-4. PubMed ID: 2682318 [TBL] [Abstract][Full Text] [Related]
25. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752 [TBL] [Abstract][Full Text] [Related]
27. Alzheimer's disease: the end of the beginning? Heston LL Psychol Med; 1990 Feb; 20(1):7-10. PubMed ID: 2181520 [No Abstract] [Full Text] [Related]
28. The genesis of the senile plaque. Further evidence in support of its neuronal origin. Pappolla MA; Omar RA; Sambamurti K; Anderson JP; Robakis NK Am J Pathol; 1992 Nov; 141(5):1151-9. PubMed ID: 1443049 [TBL] [Abstract][Full Text] [Related]
29. Pathological aging in Africans: a benign form of cerebral amyloidosis vs. pre-clinical Alzheimer's disease? Dickson DW Brain Pathol; 1996 Apr; 6(2):107-8. PubMed ID: 8737924 [No Abstract] [Full Text] [Related]
30. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities. Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597 [TBL] [Abstract][Full Text] [Related]
31. A pathological study of the association between Lewy body disease and Alzheimer's disease. Gibb WR; Mountjoy CQ; Mann DM; Lees AJ J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826 [TBL] [Abstract][Full Text] [Related]
34. The pathogenesis and progression of the pathological changes of Alzheimer's disease. Mann DM Ann Med; 1989; 21(2):133-6. PubMed ID: 2669845 [TBL] [Abstract][Full Text] [Related]
35. Structure and location of amyloid beta peptide chains and arrays in Alzheimer's disease: new findings require reevaluation of the amyloid hypothesis and of tests of the hypothesis. Rosenblum WI Neurobiol Aging; 2002; 23(2):225-30. PubMed ID: 11804706 [TBL] [Abstract][Full Text] [Related]
36. [Immunocytochemical study at the ultrastructural level of neurofibrillary degeneration in Alzheimer's disease]. Defossez A; el Hachimi K; Beauvillain JC; Perre J; Delacourte A; Foncin JF C R Acad Sci III; 1987; 304(9):217-22. PubMed ID: 3102001 [TBL] [Abstract][Full Text] [Related]
37. Diarylethene based fluorescent switchable probes for the detection of amyloid-β pathology in Alzheimer's disease. Lv G; Cui B; Lan H; Wen Y; Sun A; Yi T Chem Commun (Camb); 2015 Jan; 51(1):125-8. PubMed ID: 25384304 [TBL] [Abstract][Full Text] [Related]
38. The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease. Behrouz N; Defossez A; Delacourte A; Mazzuca M J Gerontol; 1991 Nov; 46(6):B209-12. PubMed ID: 1719062 [TBL] [Abstract][Full Text] [Related]